AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3606918 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaesthesia with isoflurane and nitrous oxide at 1.3 MAC
Number of subjects: 14
Study 3606918 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaesthesia with isoflurane and nitrous oxide at 1.5 MAC
Number of subjects: 14
Study 30549145 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received five 30- to 60-minute sessions at 2-week intervals by master's-prepared patient educators.
Number of subjects: 322
Study 30549145 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (wives)
Number of subjects: 322
Study 30549145 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (wives on chemotherapy)
Number of subjects: 322
Study 30549145 — intervention group
Group type: COMPARATOR
Intervention: Control group received the booklet, 'What's Happening to the Woman I Love?'
Number of subjects: 322
Study 28521831 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise referral schemes (ERS) for 16 weeks (32 sessions, 45-60 min per session)
Number of subjects: 1338
Study 28521831 — intervention group
Group type: EXPERIMENTAL
Intervention: ERS enhanced by seven sessions of self-management strategies (SMSs) and four telephone prompts
Number of subjects: 1338
Study 28521831 — intervention group
Group type: COMPARATOR
Intervention: Control group (general recommendations about physical activity)
Number of subjects: 1338
Study 25525743 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/d
Number of subjects: 26
Study 25525743 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/d
Number of subjects: 26
Study 23566429 — intervention group
Group type: EXPERIMENTAL
Intervention: State-of-the-art strategy including education, reminders, feedback, and optimising materials and facilities
Number of subjects: 0
Study 23566429 — intervention group
Group type: EXPERIMENTAL
Intervention: Team and leaders-directed strategy including all elements of the state-of-the-art strategy, supplemented with social activities and enhancing leadership
Number of subjects: 0
Study 21205628 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. lidocaine (Group L, n=35)
Number of subjects: 70
Study 21205628 — intervention group
Group type: COMPARATOR
Intervention: remifentanil by TCI (Group R, n=35)
Number of subjects: 70
Study 21205628 — intervention group
Group type: COMPARATOR
Intervention: remifentanil by TCI (Group R)
Number of subjects: 70
Study 21205628 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. lidocaine (Group L)
Number of subjects: 70
Study 21205628 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study 18305999 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 148
Study 18305999 — intervention group
Group type: COMPARATOR
Intervention: Non-propofol
Number of subjects: 148
Study 18305999 — intervention group
Group type: COMPARATOR
Intervention: Propofol and Non-propofol
Number of subjects: 148
Study 16533388 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure self-management program for patients with low literacy; education on self-care, daily weight measurement, diuretic dose self-adjustment, symptom recognition, picture-based materials, digital scale, scheduled follow-up.
Number of subjects: 123
Study 16533388 — intervention group
Group type: COMPARATOR
Intervention: Usual care with a generic heart failure brochure.
Number of subjects: 123
Study 11784522 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigated-tip catheter
Number of subjects: 37
Study 11784522 — intervention group
Group type: COMPARATOR
Intervention: Standard catheter
Number of subjects: 37
Study 9920082 — intervention group
Group type: EXPERIMENTAL
Intervention: Low isoflavone diet (64 +/‐ 9.2 mg/day)
Number of subjects: 14
Study 9920082 — intervention group
Group type: EXPERIMENTAL
Intervention: High isoflavone diet (128 +/‐ 16 mg/day)
Number of subjects: 14
Study 9920082 — intervention group
Group type: COMPARATOR
Intervention: Control diet (10 +/‐ 1.1 mg/day)
Number of subjects: 14
Study 9920082 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone consumption
Number of subjects: 14
Study 7593708 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual administration of triazolam (0.25 mg)
Number of subjects: 12
Study 7593708 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of triazolam (0.25 mg)
Number of subjects: 12
Study 7593708 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of triazolam (0.25 mg)
Number of subjects: 12
Study 2256974 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxpentifylline 400 mg three times a day for six months
Number of subjects: 80
Study 2256974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 2256974 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxpentifylline
Number of subjects: 80
Study 6247656 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbimazole
Number of subjects: 0
Study 6247656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6247656 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study 6247656 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (active metabolite of carbimazole)
Number of subjects: 0
Study 29343016 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl combined with midazolam
Number of subjects: 132
Study 29343016 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine
Number of subjects: 132
Study 27409593 — intervention group
Group type: EXPERIMENTAL
Intervention: AV distraction using videotaped cartoons with eyeglass system (i‐theatre™)
Number of subjects: 56
Study 27409593 — intervention group
Group type: COMPARATOR
Intervention: Control group without distraction (CTR-group)
Number of subjects: 56
Study 24056528 — intervention group
Group type: EXPERIMENTAL
Intervention: Emixustat (5, 10, 20, 30, or 40 mg)
Number of subjects: 40
Study 24056528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 23019833 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide base liner (Dycal; Dy)
Number of subjects: 37
Study 23019833 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer (Clearfil SE Bond; CSE)
Number of subjects: 37
Study 23019833 — intervention group
Group type: COMPARATOR
Intervention: Control group (sound and carious primary dentin)
Number of subjects: 37
Study 20459744 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose cyclophosphamide, doxorubicin and fluorouracil (CAF)
Number of subjects: 350
Study 17651679 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Crystalens IOL
Number of subjects: 49
Study 17651679 — intervention group
Group type: EXPERIMENTAL
Intervention: ReSTOR multifocal IOL
Number of subjects: 49
Study 17651679 — intervention group
Group type: COMPARATOR
Intervention: Crystalens IOL
Number of subjects: 49
Study 17651679 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Crystalens
Number of subjects: 49
Study 17651679 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Crystalens and ReSTOR
Number of subjects: 49
Study 17651679 — intervention group
Group type: COMPARATOR
Intervention: Bilateral multifocal IOL
Number of subjects: 49
Study 17651679 — intervention group
Group type: EXPERIMENTAL
Intervention: Accommodating and multifocal IOL combinations
Number of subjects: 49
Study 15716155 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (L-dopa) medication
Number of subjects: 20
Study 15716155 — intervention group
Group type: COMPARATOR
Intervention: No medication (off L-dopa)
Number of subjects: 20
Study 11881867 — intervention group
Group type: COMPARATOR
Intervention: 0.25 ml air injection
Number of subjects: 30
Study 11881867 — intervention group
Group type: COMPARATOR
Intervention: 0.5 ml air injection
Number of subjects: 30
Study 11881867 — intervention group
Group type: COMPARATOR
Intervention: 1 ml air injection
Number of subjects: 30
Study 11881867 — intervention group
Group type: COMPARATOR
Intervention: 2 ml air injection
Number of subjects: 30
Study 11881867 — intervention group
Group type: COMPARATOR
Intervention: 3 ml air injection
Number of subjects: 30
Study 11881867 — intervention group
Group type: COMPARATOR
Intervention: ≥4 ml air injection
Number of subjects: 30
Study 11881867 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-observer reliability
Number of subjects: 30
Study 11881867 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-observer reliability
Number of subjects: 30
Study 11881867 — intervention group
Group type: EXPERIMENTAL
Intervention: False positives
Number of subjects: 30
Study 11881867 — intervention group
Group type: EXPERIMENTAL
Intervention: False negatives
Number of subjects: 30
Study 11881867 — intervention group
Group type: EXPERIMENTAL
Intervention: Specificity
Number of subjects: 30
Study 11881867 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity
Number of subjects: 30
Study 10405580 — intervention group
Group type: EXPERIMENTAL
Intervention: CD instrumentation (n = 64)
Number of subjects: 130
Study 10405580 — intervention group
Group type: COMPARATOR
Intervention: No instrumentation (n = 66)
Number of subjects: 130
Study 7585847 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg cimetidine
Number of subjects: 0
Study 7585847 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg ranitidine
Number of subjects: 0
Study 7585847 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg famotidine
Number of subjects: 0
Study 2145136 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (54 micrograms)
Number of subjects: 32
Study 2145136 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaproterenol sulfate (1.95 mg)
Number of subjects: 32
Study 7189485 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg miconazole once daily for 6 days (A)
Number of subjects: 119
Study 7189485 — intervention group
Group type: COMPARATOR
Intervention: 400 mg miconazole once daily for 3 days (B)
Number of subjects: 119
Study 30817716 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 44
Study 30817716 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 44
Study 30817716 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling followed by Static Stretching (FR + SS)
Number of subjects: 44
Study 30817716 — intervention group
Group type: COMPARATOR
Intervention: All groups (FR, SS, FR + SS)
Number of subjects: 44
Study 28290274 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC standard dissolution
Number of subjects: 42
Study 28290274 — intervention group
Group type: COMPARATOR
Intervention: Individual tablets
Number of subjects: 42
Study 28290274 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC standard dissolution with food
Number of subjects: 42
Study 28290274 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC slow dissolution
Number of subjects: 42
Study 26950418 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven-point BG testing before and after each meal and at bedtime over a course of 3 days in 1 month (n=40)
Number of subjects: 138
Study 26950418 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-pair glucose test of pre- and postprandial BG per week (n=43)
Number of subjects: 138
Study 26950418 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-pair glucose test of pre- and postprandial BG per week (n=39)
Number of subjects: 138
Study 24143910 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipurpose contact lens solution/silicone hydrogel lens combination (renu® fresh™ and balafilcon A)
Number of subjects: 8
Study 24143910 — intervention group
Group type: COMPARATOR
Intervention: Hydrogen peroxide care system (Clear Care®)
Number of subjects: 8
Study 23268177 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrodynamic irrigation with 3% sodium hypochlorite (47 patients)
Number of subjects: 143
Study 23268177 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrodynamic irrigation with laser root canal therapy (number of patients not specified)
Number of subjects: 143
Study 23268177 — intervention group
Group type: COMPARATOR
Intervention: Conventional root canal treatment (51 patients)
Number of subjects: 143
Study 19514448 — intervention group
Group type: EXPERIMENTAL
Intervention: Vobenzyme added to standard antibiotic therapy
Number of subjects: 60
Study 17623763 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (FAC protocol: 5-fluorouracil, adriamycin, and cyclophosphamide)
Number of subjects: 30
Study 17623763 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC protocol: adriamycin and cyclophosphamide)
Number of subjects: 30
Study 17623763 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (CMF protocol: cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 30
Study 17623763 — intervention group
Group type: EXPERIMENTAL
Intervention: All chemotherapy protocols
Number of subjects: 30
Study 17623763 — intervention group
Group type: COMPARATOR
Intervention: Healthy women (control group)
Number of subjects: 30
Study 15756498 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-FDG-PET
Number of subjects: 9
Study 12009222 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional CPR instruction
Number of subjects: 262
Study 12009222 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-training
Number of subjects: 262
Study 10658309 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity nutrition intervention including individualized health risk appraisal, group sessions, mass media activities, and environmental changes.
Number of subjects: 770
Study 10658309 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity nutrition intervention
Number of subjects: 770
Study 10658309 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 770
Study 1319870 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed tablet with enteral feeding solution (Osmolite 100 ml/h started 2h before administration and continued for 4h postdose)
Number of subjects: 18
Study 1319870 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed tablet without enteral feeding solution
Number of subjects: 18
Study 1319870 — intervention group
Group type: COMPARATOR
Intervention: Oral tablet (reference)
Number of subjects: 18
Study 6369956 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose diet
Number of subjects: 11
Study 31442241 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention
Number of subjects: 715
Study 31442241 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 715
Study 29396806 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexion group (knee at 90° flexion for 12 hours, then 60° for 12 hours, combined with 1g TXA topical and 1g TXA intravenous)
Number of subjects: 90
Study 29396806 — intervention group
Group type: EXPERIMENTAL
Intervention: Extension group (knee in full extension, combined with topical and intravenous TXA)
Number of subjects: 90
Study 29396806 — intervention group
Group type: COMPARATOR
Intervention: Controlled group (knee in full extension, combined with single intravenous TXA)
Number of subjects: 90
Study 29396806 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexion group
Number of subjects: 90
Study 29396806 — intervention group
Group type: EXPERIMENTAL
Intervention: Extension group
Number of subjects: 90
Study 29396806 — intervention group
Group type: COMPARATOR
Intervention: Controlled group
Number of subjects: 90
Study 29396806 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 26778246 — intervention group
Group type: EXPERIMENTAL
Intervention: Propeller Health system (Intervention Group - IG)
Number of subjects: 495
Study 26778246 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control Group - RC)
Number of subjects: 495
Study 25676423 — intervention group
Group type: EXPERIMENTAL
Intervention: Sapacitabine
Number of subjects: 143
Study 25676423 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cytarabine (LDAC)
Number of subjects: 143
Study 23772997 — intervention group
Group type: EXPERIMENTAL
Intervention: Bath PUVA
Number of subjects: 74
Study 23772997 — intervention group
Group type: COMPARATOR
Intervention: System PUVA
Number of subjects: 74
Study 23772997 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 74
Study 20572403 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery (28 minutes of listening to a guided imagery CD)
Number of subjects: 44
Study 20572403 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study 19007042 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine (150 mg)
Number of subjects: 18
Study 19007042 — intervention group
Group type: EXPERIMENTAL
Intervention: stavudine (40 mg)
Number of subjects: 18
Study 19007042 — intervention group
Group type: EXPERIMENTAL
Intervention: nevirapine (200 mg)
Number of subjects: 18
Study 16614435 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 0
Study 16614435 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid and iron
Number of subjects: 0
Study 16614435 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid, iron, and zinc
Number of subjects: 0
Study 16614435 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement with vitamin A
Number of subjects: 0
Study 16614435 — intervention group
Group type: COMPARATOR
Intervention: Control group (Vitamin A alone)
Number of subjects: 0
Study 12664066 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injection of lidocaine in the periprostatic nerves
Number of subjects: 60
Study 12664066 — intervention group
Group type: COMPARATOR
Intervention: No anesthetic (Control)
Number of subjects: 60
Study 10857841 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) adjunctive treatment
Number of subjects: 52
Study 10857841 — intervention group
Group type: COMPARATOR
Intervention: Control group (trabeculectomy alone)
Number of subjects: 52
Study 9094916 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour dietary recall method
Number of subjects: 0
Study 9094916 — intervention group
Group type: COMPARATOR
Intervention: 3-day weighed-food records
Number of subjects: 0
Study 8511730 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ioniser
Number of subjects: 20
Study 8511730 — intervention group
Group type: COMPARATOR
Intervention: Placebo ioniser
Number of subjects: 20
Study 3667021 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation at low frequency (50 Hz)
Number of subjects: 36
Study 3667021 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation at high frequency (2000 Hz)
Number of subjects: 36
Study 3667021 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 36
Study 30687550 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinner meal replacement (388 kcal)
Number of subjects: 174
Study 30687550 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine diet)
Number of subjects: 174
Study 27271265 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based emollient (G1)
Number of subjects: 43
Study 27271265 — intervention group
Group type: EXPERIMENTAL
Intervention: Petrolatum-based emollient (G2)
Number of subjects: 43
Study 27271265 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based emollient (G3)
Number of subjects: 43
Study 24950759 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counselling for exclusive breastfeeding (EBF)
Number of subjects: 2579
Study 24950759 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 2579
Study 22544914 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose-sweetened beverage (FB)
Number of subjects: 19
Study 22544914 — intervention group
Group type: COMPARATOR
Intervention: Glucose beverage (GB)
Number of subjects: 19
Study 20149929 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental bicycle test in depressed patients
Number of subjects: 137
Study 20149929 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training intervention in depressed patients
Number of subjects: 137
Study 20149929 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting hormonal levels in depressed patients
Number of subjects: 137
Study 20149929 — intervention group
Group type: EXPERIMENTAL
Intervention: PRL response to acute exercise in depressed patients
Number of subjects: 137
Study 18672990 — intervention group
Group type: EXPERIMENTAL
Intervention: Subantimicrobial-dose doxycycline (SDD)
Number of subjects: 128
Study 18672990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 15679793 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 141
Study 15679793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 12696088 — intervention group
Group type: EXPERIMENTAL
Intervention: 902 MHz electromagnetic field (EMF) on
Number of subjects: 64
Study 12696088 — intervention group
Group type: COMPARATOR
Intervention: 902 MHz electromagnetic field (EMF) off
Number of subjects: 64
Study 10596677 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim (recombinant methionyl human granulocyte colony-stimulating factor)
Number of subjects: 258
Study 10596677 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 258
Study 10596677 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 258
Study 8967667 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone, 0.1 mg/kg of body weight per day (average dosage, 6 mg/d) for 12 weeks
Number of subjects: 178
Study 8967667 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 178
Study 8967667 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone
Number of subjects: 178
Study 8967667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study 8967667 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human growth hormone and Placebo
Number of subjects: 178
Study 1653773 — intervention group
Group type: EXPERIMENTAL
Intervention: BW 91Y (3‐deazaadenosine) at 600 pg/ml
Number of subjects: 0
Study 1653773 — intervention group
Group type: EXPERIMENTAL
Intervention: BW 91Y (3‐deazaadenosine)
Number of subjects: 0
Study 6142508 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral almitrine 200 mg/day
Number of subjects: 9
Study 30839430 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxoprofen sodium topical patch (LX-P)
Number of subjects: 242